Flerie AB's (publ) portfolio company Microbiotica has reported positive results from its Phase 1b first-in-human study of MB310 in patients with ulcerative colitis (UC). The positive data support Micr ...
(Alliance News) - IP Group PLC on Wednesday said portfolio company Microbiotica Ltd has announced positive results from a phase 1b first-in-human trail of MB310 in ulcerative colitis patients.
Potential to become a new modality in the treatment of ulcerative colitis offering prolonged remission without immune ...
Microbiotica has announced positive results in its Phase 1b First-in-Human trial, COMPOSER-1, of MB310 in ulcerative colitis (UC) patients.
DEAR DR. ROACH: I am a 64-year-old female who is in moderate health. After a monthslong bout of diarrhea, blood work, and a colonoscopy, I’ve been diagnosed with microscopic colitis. After a round of ...
DEAR DR. ROACH: I am a 64-year-old female who is in moderate health. After a monthslong bout of diarrhea, blood work, and a colonoscopy, I’ve been diagnosed with microscopic colitis. After a round of ...
Dear Dr. Roach: I am a 64-year-old female who is in moderate health. After a monthslong bout of diarrhea, blood work, and a colonoscopy, I’ve been diagnosed with microscopic colitis. After a round of ...
DEAR DR. ROACH: I am a 64-year-old female who is in moderate health. After a monthslong bout of diarrhea, blood work, and a colonoscopy, I’ve been diagnosed with microscopic colitis. After a round of ...
LeAnn Rimes documented a wellness treatment that has helped clear her body of “micro-toxins” after past health struggles. “Listening to my body and choosing what feels supportive for this season of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results